Cetera Investment Advisers
SGMO

Cetera Investment Advisers’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Cetera Investment Advisers’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-73,300
Closed -$30.8K – 4947
2025
Q4 		$30.8K Buy
+73,300
New +$38.9K ﹤0.01% 4557
2022
Q1 		– Sell
-84,355
Closed -$633K – 1988
2021
Q4 		$633K Sell
84,355
-45
-0.1% -$391 0.01% 1042
2021
Q3 		$760K Hold
84,400
– – 0.01% 893
2021
Q2 		$1.01M Hold
84,400
– – 0.02% 770
2021
Q1 		$1.06M Buy
84,400
+18,395
+28% +$248K 0.02% 655
2020
Q4 		$1.03M Buy
+66,005
New +$773K 0.02% 649

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Cetera Investment Advisers's SGMO Position: Q1 2026 in Review

Cetera Investment Advisers sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026, closing a stake of 73,300 shares — an estimated $30.8K sold.

Cetera Investment Advisers first reported a position in SGMO in Q4 2020 and held it in 6 quarters. The position peaked at $1.06M in Q1 2021. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Cetera Investment Advisers reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2026 after selling out during the quarter.
  • Cetera Investment Advisers sold 73,300 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $30.8K.
  • Cetera Investment Advisers first reported a position in SANGAMO THERAPEUTICS INC in Q4 2020 and held it in 6 quarters.
  • Cetera Investment Advisers's SANGAMO THERAPEUTICS INC position peaked at $1.06M in Q1 2021.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.